Processa Pharmaceuticals, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2015-03-24: Federal exemption Rule 506(b); Securities Act Section 4(a)(5); Types of securities offered Equity; Date of first sale 2015-03-24; Total offering amount $25,500.
- 2014-01-13: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2014-01-08; Total offering amount $175,000.
- 2012-08-10: Federal exemption Rule 505; Rule 506; Types of securities offered Equity; Date of first sale 2012-08-06; Total offering amount $1,520,000.
- 2011-10-28: Federal exemption Rule 505; Rule 506; Types of securities offered Equity; Date of first sale Yet to occur; Total offering amount $3,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2015-03-24 | Rule 506(b); Securities Act Section 4(a)(5) | Equity | 2015-03-24 | $25,500 | $25,500 | $0 | 3 |
|---|
| 2014-01-13 | Rule 506(b) | Equity | 2014-01-08 | $175,000 | $175,000 | $0 | 6 |
|---|
| 2012-08-10 | Rule 505; Rule 506 | Equity | 2012-08-06 | $1,520,000 | $1,520,000 | $0 | 44 |
|---|
| 2011-10-28 | Rule 505; Rule 506 | Equity | Yet to occur | $3,000,000 | $0 | $3,000,000 | 0 |
|---|